52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Davita Inc. Posts 4Th Quarter 2019 Results
Berkshire Hathaway Reports 29.7% Stake In Davita As Of Nov 7
Davita Inc Reports Qtrly Adjusted Net Income From Continuing Operations Per Share Of $1.53
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
2000 16th St
Kent J. Thiry
Executive Chairman of the Board
Javier J. Rodriguez
Chief Executive Officer, Director
Chief Financial Officer, Treasurer
Chief Accounting Officer, Group Vice President
James O. Hearty
Chief Compliance Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* Q4 REVENUE $2.899 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.92 BILLION
UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.
UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)
A medical care unit of DaVita Inc <DVA.N> has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.
A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.
A federal jury in Colorado has awarded $383.5 million to the families of three patients who said they suffered cardiac arrests and died soon after receiving dialysis treatments at clinics run by DaVita Inc.
* Q1 EARNINGS PER SHARE VIEW $0.93 -- THOMSON REUTERS I/B/E/S
* DAVITA INC SAYS CEO KENT THIRY'S TOTAL 2017 COMPENSATION WAS $15.3 MILLION VERSUS $12.3 MILLION IN 2016
* Q4 ADJUSTED EARNINGS PER SHARE $0.92 FROM CONTINUING OPERATIONS
* DAVITA KIDNEY CARE ISSUES STATEMENT ABOUT DAVITA RX SETTLEMENT
A pharmacy services unit of DaVita Inc will pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.
A pharmacy services unit of DaVita Inc has agreed to pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.
The largest U.S. health insurer UnitedHealth Group Inc will buy DaVita Inc's primary and urgent care services for $4.9 billion in its second acquisition this year to expand its fast-growing medical group, it said on Wednesday.
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:
UnitedHealth Group Inc said on Wednesday it would acquire kidney care services provider DaVita Inc's medical unit for about $4.9 billion in cash to expand its operations in ambulatory care services.
DaVita Inc <DVA.N>, the largest U.S. provider of kidney care services, is exploring a sale of its physician network business, DaVita Medical Group, that could value the unit at up to $4 billion, according to people familiar with the matter.
DaVita Inc <DVA.N>, the biggest U.S. dialysis services provider, swung to a third-quarter loss due to an impairment charge it took for the continued underperformance of its Medical Group healthcare delivery and management unit.
* Q3 earnings per share view $0.94 -- Thomson Reuters I/B/E/S
DaVita Inc on Tuesday reported a third-quarter loss, compared with a year-ago profit, due to higher expenses.
* DaVita provides additional information regarding patients receiving charitable premium assistance
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.